
11 - 50 employees
Founded 2015
π Pharmaceuticals
𧬠Biotechnology
Pharmaceuticals β’ Biotechnology
Achieve Life Sciences is a late-stage specialty pharmaceutical company focused on developing cytisinicline as a treatment for nicotine dependence (smoking and vaping cessation). The company is advancing cytisinicline through Phase 2 and Phase 3 ORCA trials and has submitted an NDA; its clinical program targets nicotinic receptors to reduce withdrawal and smoking satisfaction, with the goal of providing a new FDA-approved treatment option for tobacco and nicotine dependence.
π₯ 28 minutes ago
Director/Sr. Director leading trade and distribution strategy for cytisinicline, Achieve Life Sciencesβ candidate for nicotine dependence treatment. Building infrastructure and maintaining partner relationships for product launch and access.
π₯ 28 minutes ago
Executive Director/Vice President leading public policy and patient advocacy strategy in support of cytisinicline at Achieve Life Sciences. Building relationships with patient advocates, policymakers, and health coalitions.
π₯ 28 minutes ago
Sr. Director/Executive Director responsible for building Strategic Accounts team at Achieve Life Sciences. Leading engagement with health systems to drive cytisinicline adoption and integration.
πΊπΈ United States β Remote
π΅ $260k - $310k / year
β° Full Time
π Senior
π§βπΌ Account Executive
π₯ 28 minutes ago
Leads commercial operations at Achieve Life Sciences, guiding market insights, sales operations, and analytics to shape informed strategic decisions. Equips executive leadership with data-driven tools for market success.
π₯ 28 minutes ago
Senior Director leading market access contracting strategy for cytisinicline, ensuring commercial launch readiness. Collaborating across teams to develop payer agreements and access strategies.